| NSCLC | Non-small cell lung cancer |
| SCLC | Small-cell lung carcinoma |
| DPIs | Dry-powder inhalers |
| Dae | Aerodynamic diameter |
| EPR | Enhanced permeability and retention |
| PLGA | Polylactic-co-glycolic |
| PEG | Polyethylene glycol |
| CD-RES NP | Resveratrol-cyclodextrin nanoparticles |
| SF | Sorafenib |
| PLA | Poly-L-arginine |
| DOX | Doxorubicin |
| AQ | Amodiaquine |
| HPH | High-pressure homogenization |
| BSA | Bovine serum albumin |
| PEI | Polyethyleneimine |
| Cs | Chitosan |
| F | Fucoidan |
| HTCC | N-[(2-hydroxy-3- trimethylammonium)propyl] chitosan chloride |
| SLNs | Solid lipid nanoparticles |
| LPN | Lipid–polymer hybrid nanoparticles |
| NLCs | Nanostructured lipid carriers |
| SD | Sprague–Dawley |
| PFD | Pirfenidone |
| PTX | Paclitaxel |
| DLPC | Dilauroylphosphatidyl choline |
| CLH | Hydroxycamptothecin |
| 5-ALA | 5-aminolevulinic acid |
| 5-FU | 5-Fluorouracil |
| DPPC | Dipalmitoyl phosphatidylcholine |
| DPPG | Dipalmitoyl phosphatidylglycerol |
| DPPA | Dipalmitoyl phosphatidic acid |
| NEs | Nanoemulsions |
| PDI | Polydispersity index |
| LDH | Lactate dehydrogenase |
| CU | Curcumin |
| DOTAP | (N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium) or 1, 2-dioleoyl-3-trimethylammonium propane |
| LPHNs | Lipid–polymer hybrid nanoparticles |
| DLPC | Dilauroylphosphatidylcholine |
| 9NC | 9-Nitrocamptothecin |
| GPs | Gelatin nanoparticles |
| MNPs | Magnetic nanoparticles |
| MSNs | Mesoporous silica NPs |
| ZnO-NPs | Zinc oxide nanoparticles |
| Cp | Cisplatin |
| Sb-GNPs | Gemcitabine (Gem) silibinin-loaded gold nanoparticles |
| CMC | Critical micellar concentration |
| DTX | Docetaxel |
| pMDIs | Pressurized metered-dose inhalers |